{
    "2020-10-19": [
        [
            {
                "time": "",
                "original_text": "欧普康视(300595.SZ)全资子公司欧普投资拟以5828.57万元投资苏州康视",
                "features": {
                    "keywords": [
                        "欧普康视",
                        "全资子公司",
                        "欧普投资",
                        "苏州康视",
                        "投资"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "欧普康视(300595.SZ)股东欧普民生质押350万股并解除质押415.5万股",
                "features": {
                    "keywords": [
                        "欧普康视",
                        "欧普民生",
                        "质押",
                        "解除质押"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：三季报密集披露 浙江率先公布新冠疫苗价格",
                "features": {
                    "keywords": [
                        "医药生物",
                        "三季报",
                        "新冠疫苗",
                        "浙江"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业跨市场周报：冠脉支架全国集采政策落地 未来或催生两大高耗投资方向",
                "features": {
                    "keywords": [
                        "医药生物",
                        "冠脉支架",
                        "集采政策",
                        "高耗投资"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "创业板指跌幅扩大至1%，乐普医疗、贝达药业、欧普康视、康龙化成领跌",
                "features": {
                    "keywords": [
                        "创业板指",
                        "跌幅",
                        "乐普医疗",
                        "贝达药业",
                        "欧普康视",
                        "康龙化成"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医疗行业反腐利剑出鞘！揭开巨额销售费用“画皮”",
                "features": {
                    "keywords": [
                        "医疗行业",
                        "反腐",
                        "销售费用"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}